212 related articles for article (PubMed ID: 26928953)
1. DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T-Cell Acute Lymphoblastic Leukemia.
Borssén M; Haider Z; Landfors M; Norén-Nyström U; Schmiegelow K; Åsberg AE; Kanerva J; Madsen HO; Marquart H; Heyman M; Hultdin M; Roos G; Forestier E; Degerman S
Pediatr Blood Cancer; 2016 Jul; 63(7):1185-92. PubMed ID: 26928953
[TBL] [Abstract][Full Text] [Related]
2. Promoter DNA methylation pattern identifies prognostic subgroups in childhood T-cell acute lymphoblastic leukemia.
Borssén M; Palmqvist L; Karrman K; Abrahamsson J; Behrendtz M; Heldrup J; Forestier E; Roos G; Degerman S
PLoS One; 2013; 8(6):e65373. PubMed ID: 23762353
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia.
Borssén M; Nordlund J; Haider Z; Landfors M; Larsson P; Kanerva J; Schmiegelow K; Flaegstad T; Jónsson ÓG; Frost BM; Palle J; Forestier E; Heyman M; Hultdin M; Lönnerholm G; Degerman S
Clin Epigenetics; 2018; 10():31. PubMed ID: 29515676
[TBL] [Abstract][Full Text] [Related]
4. An integrated transcriptome analysis in T-cell acute lymphoblastic leukemia links DNA methylation subgroups to dysregulated TAL1 and ANTP homeobox gene expression.
Haider Z; Larsson P; Landfors M; Köhn L; Schmiegelow K; Flaegstad T; Kanerva J; Heyman M; Hultdin M; Degerman S
Cancer Med; 2019 Jan; 8(1):311-324. PubMed ID: 30575306
[TBL] [Abstract][Full Text] [Related]
5. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis.
Roman-Gomez J; Jimenez-Velasco A; Agirre X; Prosper F; Heiniger A; Torres A
J Clin Oncol; 2005 Oct; 23(28):7043-9. PubMed ID: 16192589
[TBL] [Abstract][Full Text] [Related]
6. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
7. Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China.
Wei W; Chen X; Zou Y; Chang L; An W; Wan Y; Liu T; Yang W; Chen Y; Guo Y; Zhu X
BMC Pediatr; 2015 Jul; 15():80. PubMed ID: 26174476
[TBL] [Abstract][Full Text] [Related]
8. Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001.
Burns MA; Place AE; Stevenson KE; Gutiérrez A; Forrest S; Pikman Y; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Asselin BL; Athale UH; Clavell LA; Cole PD; Gennarini LM; Kahn JM; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Sulis ML; Welch JJG; Neuberg DS; Sallan SE; Silverman LB
Pediatr Blood Cancer; 2021 Jan; 68(1):e28719. PubMed ID: 33026184
[TBL] [Abstract][Full Text] [Related]
9. CpG island methylator phenotype and its relationship with prognosis in adult acute leukemia patients.
Fu HY; Wu DS; Zhou HR; Shen JZ
Hematology; 2014 Sep; 19(6):329-37. PubMed ID: 24164743
[TBL] [Abstract][Full Text] [Related]
10. CpG island methylator phenotype redefines the prognostic effect of t(12;21) in childhood acute lymphoblastic leukemia.
Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; Calasanz MJ; Garate L; San Jose-Eneriz E; Cordeu L; Prosper F; Heiniger A; Torres A
Clin Cancer Res; 2006 Aug; 12(16):4845-50. PubMed ID: 16914570
[TBL] [Abstract][Full Text] [Related]
11. [Monitoring of minimal residual disease in children with acute lymphoblastic leukemia and its prognostic significance].
Xu XJ; Tang YM; Song H; Shi SW; Yang SL; Shen HQ; Wei J; Xu WQ; Pan BH; Zhao FY
Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):180-4. PubMed ID: 20426951
[TBL] [Abstract][Full Text] [Related]
12. The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013.
Olsson L; Ivanov Öfverholm I; Norén-Nyström U; Zachariadis V; Nordlund J; Sjögren H; Golovleva I; Nordgren A; Paulsson K; Heyman M; Barbany G; Johansson B
Br J Haematol; 2015 Sep; 170(6):847-58. PubMed ID: 26018335
[TBL] [Abstract][Full Text] [Related]
13. [Outcome of childhood T-cell acute lymphoblastic leukemia: a report of 99 cases].
Cai JY; Xue HL; Chen J; Shen SH; Pan C; Wang X; Zhou M; Tang YJ; Gao YJ; Wang JM; Tang JY
Zhonghua Er Ke Za Zhi; 2016 Jun; 54(6):456-60. PubMed ID: 27256235
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary results of the use of MRD test among children with acute lymphoblastic leukaemia].
Raciborska A; Wypych A; Rokicka-Milewska R; Siedlecki JA; Kulik J
Przegl Lek; 2004; 61 Suppl 2():62-6. PubMed ID: 15686049
[TBL] [Abstract][Full Text] [Related]
15. High white blood cell count at diagnosis of childhood acute lymphoblastic leukaemia: biological background and prognostic impact. Results from the NOPHO ALL-92 and ALL-2000 studies.
Vaitkevičienė G; Forestier E; Hellebostad M; Heyman M; Jonsson OG; Lähteenmäki PM; Rosthoej S; Söderhäll S; Schmiegelow K;
Eur J Haematol; 2011 Jan; 86(1):38-46. PubMed ID: 21077959
[TBL] [Abstract][Full Text] [Related]
16. Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia.
Petit A; Trinquand A; Chevret S; Ballerini P; Cayuela JM; Grardel N; Touzart A; Brethon B; Lapillonne H; Schmitt C; Thouvenin S; Michel G; Preudhomme C; Soulier J; Landman-Parker J; Leverger G; Macintyre E; Baruchel A; Asnafi V;
Blood; 2018 Jan; 131(3):289-300. PubMed ID: 29051182
[TBL] [Abstract][Full Text] [Related]
17. [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase].
zur Stadt U; Harms DO; Schlüter S; Jorch N; Spaar HJ; Nürnberger W; Völpel S; Gutjahr P; Schrappe M; Janka G; Kabisch H
Klin Padiatr; 2000; 212(4):169-73. PubMed ID: 10994545
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhood.
Mussolin L; Pillon M; Conter V; Piglione M; Lo Nigro L; Pierani P; Micalizzi C; Buffardi S; Basso G; Zanesco L; Rosolen A
J Clin Oncol; 2007 Nov; 25(33):5254-61. PubMed ID: 18024872
[TBL] [Abstract][Full Text] [Related]
19. Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.
Ratei R; Schabath R; Karawajew L; Zimmermann M; Möricke A; Schrappe M; Ludwig WD
Klin Padiatr; 2013 May; 225 Suppl 1():S34-9. PubMed ID: 23700065
[TBL] [Abstract][Full Text] [Related]
20. [Clinical Characteristics and Treatment Efficacy of Children with SIL/TAL1 Positive T-Cell Acute Lymphoblastic Leukemia].
Liu X; Li WJ; Zhao XX; Gao C; Zhao W; Jiang J; Zhang RD; Xie J; Shi HW; Wang B; Zhang YH; Ma XL; Zhou X; Wu MY; Cui L; Li ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):681-6. PubMed ID: 27342490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]